Clinical research is a branch of healthcare science that determines the safety and effectiveness of medications, devices, diagnostic products and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease and Pharmacovigilance, also known as drug safety, is the pharmaceutical science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products.
The etymological roots for the word “pharmacovigilance” are pharmakon and vigilare.
In the course of clinical trials, drugs are tested for their safety and efficacy on selected human beings only. When drugs are marketed, they are exposed to larger population, hence require close monitoring, which is termed as post marketing surveillance or more precisely pharmacovigilance, which majorly depends on spontaneous reporting of adverse drug reaction (ADR).
The World Health Organization (WHO) defines an ADR as any drug effect, which is noxious, unintended and undesired and occur at normal therapeutic doses. Pharmacovigilance is defined by the World Health Organization (WHO) as ’the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem’.
The main objective of pharmacovigilance is to protect patients from preventable harm by identifying previously unrecognized adverse drug reactions, interpreting pre-disposing factors, contradicting safety signals, which does not act in accordance with the expected safety and efficacy of the drugs, and reckoning risk over benefits. In 2002, in excess of 65 nations have their own pharmacovigilance centres.
WHO Collaborating Centre facilitates International Drug Monitoring, known as the Uppsala Monitoring centre (UMC) situated in Sweden, firmly associated with WHO since 1978. The main purpose of the Uppsala monitoring centre is to standardize signals detected and communicate among countries to expedite identification of signals.
These courses are suitable for the candidates who wish to join any pharmaceutical industry or pursue research in the future.
There are various institutes and colleges in Delhi, Mumbai, Pune, Bangalore, Chennai, Hyderabad, Kolkata offering enormous courses in clinical research and pharmacovigilance in India. Online certificate course in clinical research is a forthcoming field in medical health care sector and it offers many junctures to scholars who wish to make their careers in clinical research. One of the top institute offering clinical research and pharmacovigilance courses in India is Institute of Clinical Research (India) – ICRI, Delhi/ NCR
ICRI is a topmost institute in India with further than 8 premises, 13 centres of excellence with a global alumnus of more than, 18,000+ scholars. ICRI offers new- age undergraduate and postgraduate programs of exceptional Indian and global universities through its unique University- Industry Partnership model. With a pan-India presence and association with leading institutions in India, ICRI focuses on futuristic diligence that is specifically designed to make scholars job-ready.
ICRI carriers a charge of bringing in the finest of International Practices in the field of Life sciences, Aviation, Technology, Logistics Management, Clinical Research, Pharmacovigilance and Healthcare Management to its operations with tie- ups to Internationally known Associations in the separate fields.
ICRI is an award winning institute offers job acquainted program in Pharmacovigilance and Clinical Research was India’s first and till date the most sought after programme within the education fraternity. ICRI has more than 250 company tie- up’s countenance India with further than, 2000 students studying in the pharmacovigilance and Clinical Research course in ICRI, making it the largest group of pharmacovigilance and clinical research. Professionals passed from a particular institution with a handsome starting payment in both the courses.
A recent check showed ICRI scholars started with 20% more pharmacovigilance and clinical research starting payment than non-ICRI scholars in the clinical research did and pharmacovigilance industry did. Also, more than 75% of professionals working in the clinical research and pharmacovigilance industry in the last 11 years are ICRI pass out’s, thus YOUR chances of being hired for jobs In Pharmacovigilance & clinical research industry increases. ICRI in collaboration with leading hospitals ensures practical training at hospitals & leading CRO’s.
ICRI provides Digital, Internet- enabled delivery inflexibility in terms of place and place, Job- acquainted program in Pharmacovigilance and clinical research, Class designed as per assiduity conditions, jobs in Pharmacovigilance and clinical research leading MNCs and Indian IT companies, largely good faculty members and excellent career openings.
